Dr Anthony Boateng BSc, MSc, PhD, PgCHE, FHEA

Dr Anthony Osei Boateng joined the School of Science in the Faculty of Engineering and Science as an Industrial Scientist in June 2023.

Anthony is an HCPC Registered Clinical Scientist (Pathologist) with a PhD in Biomedical Science from University of Westminster where he investigated hepatoprotective properties of phytochemicals: gentiopicroside, swerosides, swertiamarin and silymarin against non-alcoholic fatty liver disease (NAFLD) and MSc in Pharmaceutical Science from London Metropolitan University where he developed novel Plasmodium falciparum GDH inhibitors as potential antimalarials and designed  Anthony's Roller Compactor machine for making immediate release tablets modified with thermostatic fins.

He is a Fellow of UK's Higher Education Academy and has undertaken and received distinction in PRESTige Post Graduate Certificate in Higher Education (PGCHE). He is an Ambassador for the STEM Learning Higher Education Advisory Group which supports UK-wide STEM education and engagement to enable young people to excel in their STEM education.

In 2020 he co-founded a London-based biotech company, An & An Global, which operates in over 27 countries in the field of medical research with special focus on pharmacogenomics research and manufacture/distribution of medical devices for detecting diseases such as malaria, HIV, hepatitis, dengue fever, COVID-19, drug abuse detection test kits, etc. In 2021, he was listed as one of 30 visionaries to watch in the biotech industry by the Databird Business Journal in USA.

Anthony is focused on enterprise, R&KE and was recruited in 2019 as part of the London LD12 cohort by Entrepreneur First ($4b USD combined portfolio) to come up with ideas to disrupt UK’s biotech industry. This program gave Anthony the opportunity to ideate with leading authorities in UK’s 100K genomics project, National Institute of Health and Care Excellence (NICE) and participate in the pharmacogenomics conference at John Hopkins University in May 2019.  He has consulted for global brands including Sona Nanotech in Canada and Abingdon Health in UK. He has consulted on projects including a $30million USD pharma / vaccine manufacturing plant development in Senegal and other projects in Ethiopia, Ghana and Botswana.

He has over 15 years’ experience in medical research, having worked in Ghana as a Clinical Pathology Researcher at Noguchi Memorial Institute for Medical Research on malaria research projects in collaboration with New York University, Harvard University and Yale University. Anthony was a member of Microsoft’s DreamSpark and BizSpark Program in 2012 where he developed skills in software and app design using tools and training provided by the Microsoft DreamSpark Program. During that period, Anthony also trained in developing apps for android and iOs devices.

He studied his BSc in Herbal Medicine at the Kwame Nkrumah University of Science and Technology (KNUST) in Ghana and received advanced training in research and development of medicinal plants jointly from Tianjin University for Traditional Chinese Medicine (TUTCM) and University of Nairobi, Kenya. Anthony also worked with the WHO Collaboration Centre for Scientific Research into Plant Medicine (CSRPM) on WHO funded projects.

In 2012, Anthony received a citation from Queen Elizabeth II for an article he wrote for her Diamond Jubilee.

He is open to research collaborations, knowledge transfer partnerships (KTP) with industry, PhD Supervision, fostering employer relations including placement, apprenticeship, internship and graduate opportunities for Greenwich Students.